|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Two complaint devices were received and forwarded to the manufacturer for evaluation.The first device shows signs of activation at the tip and the distal section of the shaft shows signs of damage both to articulating feature.The device failed continuity tests on the active circuit and hipot.Further investigation revealed that the active wire has become severed during use.The nature of the damage to the articulating feature of the device would suggest the device has been subjected to undue force during use or continued usage past the articulation failure.The second device shows signs of activation at the tip and the distal section of the shaft shows signs of damage both to articulating feature.The device failed continuity tests on the return circuit.Further investigation revealed that the return wire has become severed during use.The nature of the damage to the articulating feature of the device would suggest the device has been subjected to undue force during use or continued usage past the articulation failure.The dhr review performed for complaint device lot number u1512011 has not indicated any issues with the manufacturing process that might explain the failures observed.Further, a review into the depuy synthes mitek complaints system revealed no other complaints of any kind for this batch of devices that were released to distribution.From the investigation, the cause of the reported failure for both devices to be misuse/excessive force therefore no corrective actions could be determined to implement.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.¿ dhr review: ¿ part number: 225030; ¿ supplier lot number: u1512011; ¿ release to warehouse date: 12/22/2015; ¿ manufacturing date: 12/16/2015; ¿ expiration date: 2/28/2017; ¿ supplier: (b)(4); ¿ manufacturing site: (b)(4); ¿ no ncrs were generated during production.Review of the device history record(s) showed that there were no issues during the manufacture of this product, and any subcomponents, which would contribute to this complaint condition.This report is being filed from the etq complaint management system as required under mitek's corrective and preventative actions (capa) to file usa fda mdr missed malfunctions.Udi: (b)(4).
|